Financial statements Octapharma Poland
Balance sheet data of OCTAPHARMA POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 792 495,69 | 2 850 751,89 | 2 971 948,10 | 2 973 164,54 | 3 204 884,41 | 3 491 896,13 |
| A. Fixed assets | 83 514,97 | 36 878,97 | 35 976,01 | 26 018,00 | 29 837,00 | 207 294,22 |
| B. Current assets | 2 708 980,72 | 2 813 872,92 | 2 935 972,09 | 2 947 146,54 | 3 175 047,41 | 3 284 601,91 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 792 495,69 | 2 850 751,89 | 2 971 948,10 | 2 973 164,54 | 3 204 884,41 | 3 491 896,13 |
| A. Equity | 2 176 673,06 | 2 350 934,47 | 2 482 310,08 | 2 613 473,27 | 2 774 094,22 | 2 960 276,70 |
| B. Liabilities and provisions for liabilities | 615 822,63 | 499 817,42 | 489 638,02 | 359 691,27 | 430 790,19 | 531 619,43 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 178 696,57 | 130 304,95 | 120 313,83 | 77 596,41 | 117 179,48 | 136 420,16 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.